Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00885664 · ClinicalTrials.gov registry record · Phase 4

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

A Phase 4 study of HIV Infections, sponsored by University of Cincinnati.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target
1
Study location

NCT00885664 is a Phase 4 study of HIV Infections that has completed, run by University of Cincinnati. The registered enrollment target is 60 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00885664, a Phase 4 study of HIV Infections, has completed, sponsored by University of Cincinnati.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purposes of this study are: 1. To understand whether the use of HIV therapy in persons with more advanced HIV disease results in greater side effects. 2. To determine whether these side effects can be related to greater activation of the immune system.

Conditions Studied

HIV Infections

Interventions

  • DRUG Truvada (tenofovir/emtricitabine)
  • DRUG Kaletra (lopinavir/ritonavir)

Study Locations (1)

Ohio

  • University of Cincinnati AIDS Clinical Trials Unit - Cincinnati

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2005-10
Est. Completion 2010-03
Phase Phase 4

Sponsor

University of Cincinnati

245 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00885664

The ClinicalTrials.gov registry entry for NCT00885664 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (87% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Truvada (tenofovir/emtricitabine) is the first listed.

NCT00885664 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00885664 about?

NCT00885664 is a clinical study titled "Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection". The purposes of this study are: 1. To understand whether the use of HIV therapy in persons with more advanced HIV disease results in greater side effects. 2. To determine whether these side effects can be related to greater activation of the immune system.

What is the current status of trial NCT00885664?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2005-10. Estimated completion is 2010-03.

What conditions does trial NCT00885664 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00885664?

The interventions under investigation include: Truvada (tenofovir/emtricitabine) (DRUG), Kaletra (lopinavir/ritonavir) (DRUG).

Who is sponsoring clinical trial NCT00885664?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00885664 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.